{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:03:51Z","timestamp":1789693431239,"version":"4.0.1"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cellsig.2026.112834","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:05:16Z","timestamp":1787267116000},"page":"112834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emergence of glycolysis-lactate-Lactylation Axis in breast cancer: Mechanisms, tumour progression, and therapeutic implications"],"prefix":"10.1016","volume":"148","author":[{"given":"Ishika","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Sundram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathvik","family":"Belagodu Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javedh","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Arockiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishabha","family":"Malviya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2026.112834_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","article-title":"Awareness and current knowledge of breast cancer","volume":"50","author":"Akram","year":"2017","journal-title":"Biol. Res."},{"key":"10.1016\/j.cellsig.2026.112834_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20892\/j.issn.2095-3941.2025.0173","article-title":"Lactate and lactylation in breast cancer: current understanding and therapeutic opportunities","author":"Huang","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112834_bb0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of TUMORS in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112834_bb0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10555-025-10264-4","article-title":"Lactate metabolism and lactylation in breast cancer: mechanisms and implications","volume":"44","author":"Qiao","year":"2025","journal-title":"Cancer Metastasis Rev."},{"issue":"7779","key":"10.1016\/j.cellsig.2026.112834_bb0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"7779","key":"10.1016\/j.cellsig.2026.112834_bb0035","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/d41586-019-03122-1","article-title":"Histone lactylation links metabolism and gene regulation","volume":"574","author":"Izzo","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41420-025-02334-x","article-title":"Anaerobic metabolism promotes breast cancer survival via Histone-3 Lysine-18 lactylation mediating PPARD axis","volume":"11","author":"Xu","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cellsig.2026.112834_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1328679","article-title":"Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer","volume":"15","author":"Cui","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0050","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1038\/s41598-025-92666-6","article-title":"Appraising histone H4 lysine 5 lactylation as a novel biomarker in breast cancer","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12920-023-01726-1","article-title":"Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer","volume":"16","author":"Deng","year":"2023","journal-title":"BMC Med. Genomics"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0060","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s12672-025-03663-0","article-title":"Research advances of lactylation modification in breast cancer","volume":"16","author":"Shen","year":"2025","journal-title":"Discov. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112834_bb0065","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in Cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112834_bb0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cac2.12549","article-title":"The regulatory roles and clinical significance of glycolysis in tumor","volume":"44","author":"Qiao","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.cellsig.2026.112834_bb0075","article-title":"Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic-associated molecular subtypes and genomic mutations","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112834_bb0080","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1007\/s10147-025-02916-w","article-title":"Future perspective of clinical usefulness of metabolic and mitochondrial heterogeneity in triple-negative breast cancers","volume":"30","author":"Li","year":"2025","journal-title":"Int. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112834_bb0085","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00044-025-03514-1","article-title":"Direct targeting of GLUT1 in cancer: a decade of inhibitor discovery and medicinal chemistry insights","volume":"35","author":"Meng","year":"2026","journal-title":"Med. Chem. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112834_bb0090","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s12253-012-9500-5","article-title":"Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers","volume":"18","author":"Krzeslak","year":"2012","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.cellsig.2026.112834_bb0095","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1158\/1538-7445.AM2024-5423","article-title":"Abstract 5423: selective inhibition of glucose transporter 3 (GLUT3) suppresses triple-negative breast cancer cell migration by modulating actin cytoskeleton and cell mechanics","volume":"84, no. 6_Supplement","author":"Kim","year":"2024","journal-title":"Cancer Res."},{"issue":"51","key":"10.1016\/j.cellsig.2026.112834_bb0100","doi-asserted-by":"crossref","first-page":"84999","DOI":"10.18632\/oncotarget.13113","article-title":"PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells","volume":"7","author":"Phadngam","year":"2016","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.cellsig.2026.112834_bb0105","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1021\/acs.jmedchem.3c00118","article-title":"Degradation of hexokinase 2 blocks glycolysis and induces GSDME-dependent Pyroptosis to amplify immunogenic cell death for breast Cancer therapy","volume":"66","author":"Sang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41420-023-01412-2","article-title":"Let-7b-5p inhibits breast cancer cell growth and metastasis via repression of hexokinase 2-mediated aerobic glycolysis","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cellsig.2026.112834_bb0115","article-title":"The role and therapeutic potential of glucose metabolism in multidrug resistance of cancer","volume":"13","author":"Wang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112834_bb0120","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.7150\/jca.71592","article-title":"Hexokinase 2 is a pivot for lovastatin-induced glycolysis-to-autophagy reprogramming in triple-negative breast Cancer cells","volume":"13","author":"Xue","year":"2022","journal-title":"J. Cancer"},{"issue":"45","key":"10.1016\/j.cellsig.2026.112834_bb0125","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/s41388-018-0386-x","article-title":"PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer","volume":"37","author":"Yang","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s12905-025-04039-w","article-title":"Lactate dehydrogenase a is a crucial biomarker that affects the prognosis, chemotherapy effect, and immune infiltration of breast cancer","volume":"25","author":"Xia","year":"2025","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.cellsig.2026.112834_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.747001","article-title":"Lactate dehydrogenase a or B knockdown reduces lactate production and inhibits breast Cancer cell motility in vitro","volume":"12","author":"Khajah","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112834_bb0140","article-title":"Lactate dehydrogenase-a (LDH-A) preserves Cancer Stemness and recruitment of tumor-associated macrophages to promote breast Cancer progression","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"40","key":"10.1016\/j.cellsig.2026.112834_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202511849","article-title":"Lactate dehydrogenase C4 accelerates triple-negative breast cancer progression by promoting Acetyl-CoA acyltransferase 2 lactylation to increase free fatty acid accumulation","volume":"12","author":"Cui","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.37349\/etat.2024.00210","article-title":"Exploring monocarboxylate transporter inhibition for cancer treatment","volume":"5","author":"Koltai","year":"2024","journal-title":"Explor. Target. Antitumor Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0155","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1080\/21655979.2021.1951928","article-title":"Comprehensive analysis of Monocarboxylate transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis","volume":"12","author":"Yuan","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.cellsig.2026.112834_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.598626","article-title":"Lactate metabolism and immune modulation in breast Cancer: a focused review on triple negative breast Tumors","volume":"10","author":"Naik","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","article-title":"Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43556-026-00427-2","article-title":"Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities","volume":"7","author":"Yu","year":"2026","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.cellsig.2026.112834_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1416472","article-title":"Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target","volume":"12","author":"Zhao","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cellsig.2026.112834_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1370800","article-title":"Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment","volume":"15","author":"Zhi","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0185","doi-asserted-by":"crossref","first-page":"21933","DOI":"10.1038\/s41598-020-78833-x","article-title":"Upregulation of PI3K\/AKT\/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells","volume":"10","author":"Hamadneh","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112834_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.mocell.2025.100198","article-title":"Metabolic regulation by p53: implications for cancer therapy","volume":"48","author":"Koo","year":"2025","journal-title":"Mol. Cells"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112834_bb0195","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/cells14080598","article-title":"Deciphering the controversial role of TP53 inducible glycolysis and apoptosis regulator (TIGAR) in Cancer metabolism as a potential therapeutic strategy","volume":"14","author":"AlMaazmi","year":"2025","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112834_bb0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.humpath.2011.04.021","article-title":"Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer","volume":"43","author":"Won","year":"2012","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112834_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tibs.2019.12.004","article-title":"Histone Lactylation: a new role for glucose metabolism","volume":"45","author":"Liberti","year":"2020","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s43556-025-00275-6","article-title":"Histone and non-histone lactylation: molecular mechanisms, biological functions, diseases, and therapeutic targets","volume":"6","author":"Peng","year":"2025","journal-title":"Mol. Biomed."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0215","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/s41467-024-47900-6","article-title":"HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription","volume":"15","author":"Niu","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s40364-025-00849-0","article-title":"Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies","volume":"13","author":"Xiao","year":"2025","journal-title":"Biomark. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112834_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi6696","article-title":"Class I histone deacetylases (HDAC1\u20133) are histone lysine delactylases","volume":"8","author":"Moreno-Yruela","year":"2022","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112834_bb0230","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","article-title":"Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis","volume":"187","author":"Zong","year":"2024","journal-title":"Cell"},{"issue":"8036","key":"10.1016\/j.cellsig.2026.112834_bb0235","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41586-024-07992-y","article-title":"AARS1 and AARS2 sense l-lactate to regulate cGAS as global lysine lactyltransferases","volume":"634","author":"Li","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41422-023-00864-6","article-title":"Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation","volume":"34","author":"Mao","year":"2024","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112834_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174587","article-title":"The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer","volume":"134","author":"Ju","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cellsig.2026.112834_bb0250","article-title":"Non-histone lactylation: unveiling its functional significance","volume":"13","author":"Shi","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41420-025-02349-4","article-title":"Lactylation in cancer: metabolic mechanism and therapeutic strategies","volume":"11","author":"Sui","year":"2025","journal-title":"Cell Death Discov."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112834_bb0260","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41556-025-01635-8","article-title":"Emerging roles of lysine lactyltransferases and lactylation","volume":"27","author":"Zong","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellsig.2026.112834_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1510975","article-title":"Recent advances of lysine lactylation in prokaryotes and eukaryotes","volume":"11","author":"Zhao","year":"2025","journal-title":"Front. Mol. Biosci."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112834_bb0270","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1158\/0008-5472.CAN-24-4394","article-title":"Lactylation in Cancer: advances, challenges, and future perspectives","volume":"85","author":"Zong","year":"2025","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112834_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002666","article-title":"KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase a (LDHA) and up-regulating H3K18 lactylation","volume":"22","author":"Hou","year":"2024","journal-title":"PLoS Biol."},{"key":"10.1016\/j.cellsig.2026.112834_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111468","article-title":"Promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation","volume":"124","author":"Li","year":"2024","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112834_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24777","article-title":"Lactylation-related gene signature for prognostic prediction and immune infiltration analysis in breast cancer","volume":"10","author":"Jiao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.cellsig.2026.112834_bb0290","article-title":"AF9\/KLF2 gene regulatory circuit links histone lactylation to breast cancer metastasis","volume":"23","author":"Ma","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellsig.2026.112834_bb0295","article-title":"Lactylation, an emerging hallmark of metabolic reprogramming: current progress and open challenges","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112834_bb0300","article-title":"Role of PFKM lactylation in glycolysis regulation in endometrial cancer cells","volume":"12","author":"Wang","year":"2025","journal-title":"Genes Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40364-026-00898-z","article-title":"Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications","volume":"14","author":"Wu","year":"2026","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cellsig.2026.112834_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1563303","article-title":"Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives","volume":"16","author":"Gu","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0315","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2026.112834_bb0320","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2025.90","article-title":"Lactylation: a novel driver of drug resistance in the tumor microenvironment","author":"Li","year":"2025","journal-title":"Cancer Drug Resistance"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112834_bb0325","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3390\/cancers17111793","article-title":"Lactate is a major promotor of breast Cancer cell aggressiveness","volume":"17","author":"Khajah","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0330","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1186\/s12885-023-11631-6","article-title":"Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and notch ligand DLL4","volume":"23","author":"Lund\u00f8","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2026.112834_bb0335","article-title":"Lactylation in tumor: mechanisms and therapeutic potentials","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0340","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41467-025-67091-y","article-title":"Lactate mitochondrial oxidation drives stemness potential in metastatic breast cancer","volume":"17","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112834_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1675480","article-title":"Lactylation as a cross-regulatory node in tumor metabolism and epigenetics: insights and therapeutic implications","volume":"16","author":"Lv","year":"2025","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112834_bb0350","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell\u2013derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112834_bb0355","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/biom14121646","article-title":"Lactate and Lactylation: dual regulators of T-cell-mediated tumor immunity and immunotherapy","volume":"14","author":"Hao","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.cellsig.2026.112834_bb0360","article-title":"Lactylation in tumor immune escape and immunotherapy: multifaceted functions and therapeutic strategies","volume":"8","author":"Li","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.cellsig.2026.112834_bb0365","article-title":"Lactylation and tumor immune regulation: insights from recent studies","volume":"16","author":"Li","year":"2026","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112834_bb0370","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","article-title":"H3K18 lactylation potentiates immune escape of non\u2013small cell lung cancer","volume":"84","author":"Zhang","year":"2024","journal-title":"Cancer Res."},{"issue":"95","key":"10.1016\/j.cellsig.2026.112834_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi4191","article-title":"A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression","volume":"9","author":"Plebanek","year":"2024","journal-title":"Sci. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112834_bb0380","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41590-025-02178-8","article-title":"Targeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment","volume":"26","author":"Jin","year":"2025","journal-title":"Nat. Immunol."},{"issue":"69","key":"10.1016\/j.cellsig.2026.112834_bb0385","doi-asserted-by":"crossref","first-page":"113977","DOI":"10.18632\/oncotarget.23048","article-title":"Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2026.112834_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1573039","article-title":"Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential","volume":"16","author":"Jin","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112834_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70499","article-title":"Exploring the mechanisms of mutual influence between lactylation and macrophage polarization in the context of disease","volume":"15","author":"Guo","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112834_bb0400","article-title":"Lactate and lactylation in macrophage metabolic reprogramming: current progress and outstanding issues","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112834_bb0405","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.7150\/thno.105276","article-title":"Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"issue":"7850","key":"10.1016\/j.cellsig.2026.112834_bb0410","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41586-021-03327-3","article-title":"Enabling conditions for an equitable and sustainable blue economy","volume":"591","author":"Cisneros-Montemayor","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0415","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41392-021-00598-0","article-title":"Lactate-avid regulatory T cells: metabolic plasticity controls immunosuppression in tumour microenvironment","volume":"6","author":"Multhoff","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112834_bb0420","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3892\/mmr.2024.13413","article-title":"Influence of lactate in resistance to anti-PD-1\/PD-L1 therapy: mechanisms and clinical applications (review)","volume":"31","author":"Zeng","year":"2024","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112834_bb0425","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","article-title":"Lactylation in cancer: current understanding and challenges","volume":"42","author":"Li","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2026.112834_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1697008","article-title":"Lactylation in cancer: mechanistic insights, tumor microenvironment, and therapeutic horizons","volume":"16","author":"Yang","year":"2026","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0435","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12967-025-06246-3","article-title":"Cancer-associated fibroblasts promote doxorubicin resistance in triple-negative breast cancer through enhancing ZFP64 histone lactylation to regulate ferroptosis","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"27","key":"10.1016\/j.cellsig.2026.112834_bb0440","doi-asserted-by":"crossref","first-page":"41559","DOI":"10.18632\/oncotarget.9490","article-title":"Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer","volume":"7","author":"Upreti","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2026.112834_bb0445","first-page":"1","article-title":"MCT4\/lactate promotes PD-L1 glycosylation in triple-negative breast Cancer cells","volume":"2022","author":"Duan","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.cellsig.2026.112834_bb0450","article-title":"Lactylation and antitumor immunity","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112834_bb0455","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176851","article-title":"Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation","volume":"134","author":"Wang","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cellsig.2026.112834_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1530567","article-title":"The lactylation modification of proteins plays a critical role in tumor progression","volume":"15","author":"Yi","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112834_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1665097","article-title":"The role of lactylation in breast cancer development: mechanisms, clinical translation and new strategies for treatment","volume":"15","author":"Lu","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0470","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41698-025-01198-9","article-title":"The regulatory roles and therapeutic strategies of the solute carrier transporters in cancer metabolism","volume":"10","author":"Zhang","year":"2026","journal-title":"npj Precis. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0475","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12885-025-14141-9","article-title":"GLUT1 inhibition by BAY-876 induces metabolic changes and cell death in human colorectal cancer cells","volume":"25","author":"Hayashi","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0480","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41420-022-01074-6","article-title":"The combination of hydroxychloroquine and 2-deoxyglucose enhances apoptosis in breast cancer cells by blocking protective autophagy and sustaining endoplasmic reticulum stress","volume":"8","author":"Zhou","year":"2022","journal-title":"Cell Death Discov."},{"issue":"3\u20134","key":"10.1016\/j.cellsig.2026.112834_bb0485","doi-asserted-by":"crossref","first-page":"100","DOI":"10.18632\/genesandcancer.9","article-title":"Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells","volume":"5","author":"Zhang","year":"2014","journal-title":"Genes Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112834_bb0490","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112834_bb0495","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/cancers18040618","article-title":"Emerging protein targets in triple-negative breast Cancer: beyond conventional therapy","volume":"18","author":"Previtali","year":"2026","journal-title":"Cancers (Basel)."},{"issue":"8021","key":"10.1016\/j.cellsig.2026.112834_bb0500","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112834_bb0505","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A phase I dose-escalation study of AZD3965, an Oral Monocarboxylate transporter 1 inhibitor, in patients with advanced Cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112834_bb0510","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/cancers13030569","article-title":"In vitro and in vivo characterization of MCT1 inhibitor AZD3965 confirms preclinical safety compatible with breast Cancer treatment","volume":"13","author":"Benyahia","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112834_bb0515","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.7150\/thno.73223","article-title":"Histone acetyltransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112834_bb0520","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404899122","article-title":"Dynamic investigation of hypoxia-induced L-lactylation","volume":"122","author":"Gao","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112834_bb0525","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2024.10.015","article-title":"ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion","volume":"37","author":"Zhu","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2026.112834_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1394685","article-title":"Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells","volume":"15","author":"Esquea","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112834_bb0535","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1021\/acschembio.1c00863","article-title":"Uncovering robust Delactoylase and Depyruvoylase activities of HDAC isoforms","volume":"17","author":"Zessin","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.cellsig.2026.112834_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00092","article-title":"Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of Cancer: achieving the full therapeutic potential of HDACi","volume":"8","author":"Suraweera","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0545","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.celrep.2019.08.068","article-title":"Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy","volume":"29","author":"Renner","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112834_bb0550","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0555","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/acsnanomed.5c00042","article-title":"Breaking glycolysis barriers to immunotherapy with nanomedicines","volume":"1","author":"Zhang","year":"2026","journal-title":"ACS Nano Med."},{"key":"10.1016\/j.cellsig.2026.112834_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.01.004","article-title":"Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin","volume":"296","author":"Abumanhal-Masarweh","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.cellsig.2026.112834_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1661697","article-title":"Insights into recent findings and therapeutic potential of nonhistone lactylation in cancer","volume":"12","author":"Jia","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cellsig.2026.112834_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101758","article-title":"Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression","volume":"37","author":"Pandkar","year":"2023","journal-title":"Transl. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112834_bb0575","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314128121","article-title":"KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis","volume":"121","author":"Xie","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112834_bb0580","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7858","key":"10.1016\/j.cellsig.2026.112834_bb0585","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:19:54Z","timestamp":1789690794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826004924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":117,"alternative-id":["S0898656826004924"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112834","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of glycolysis-lactate-Lactylation Axis in breast cancer: Mechanisms, tumour progression, and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112834"}}